Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Metadata
Title
Methyl‐substituted diindolylmethanes as inhibitors of estrogen‐induced growth of T47D cells and mammary tumors in rats
Authors
Andrew McDougal
Mona Sethi Gupta
Derek Morrow
Kavita Ramamoorthy
Jeong‐Eun Lee
Stephen H. Safe
Publication date
01-03-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010608000074

Other articles of this Issue 2/2001

Breast Cancer Research and Treatment 2/2001 Go to the issue

OriginalPaper

Metastatic bone pain palliation with 89‐Sr and 186‐Re‐HEDP in breast cancer patients

OriginalPaper

Second primary breast cancer in men

OriginalPaper

Are medical oncologists biased in their treatment of the large woman with breast cancer?

OriginalPaper

Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma

OriginalPaper

Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors

OriginalPaper

Generation of reactive oxygen species by xanthine derivatives in MDA‐MB‐231 human breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits